Graphex Group Appoints Two Directors, Partially Addresses HKSE Listing Rule Non-Compliance
summarizeSummary
Graphex Group announced the appointment of an Executive Director and an Independent Non-Executive Director, which partially resolves prior non-compliance with HKSE Listing Rules, though significant issues regarding board composition and audit committee membership remain.
check_boxKey Events
-
New Director Appointments
Mr. Zhao Aiyong has been appointed as an Executive Director, and Mr. Ren Chunyu as an Independent Non-Executive Director (INED) and a member of the Audit, Remuneration, and Nomination Committees.
-
Partial Compliance Achieved
The company now complies with HKSE Listing Rules 3.25 and 3.27A regarding the composition of the Remuneration and Nomination Committees, respectively.
-
Significant Non-Compliance Remains
Graphex Group still does not meet the minimum number of INEDs, the minimum number of members in the audit committee, and the requirement for directors of different genders under HKSE Listing Rules.
-
Three-Month Deadline for Remediation
The company is required to appoint sufficient INEDs and audit committee members within three months to comply with Rules 3.10(1), 3.10A, and 3.21.
auto_awesomeAnalysis
This filing provides an update on Graphex Group's efforts to address its non-compliance with Hong Kong Stock Exchange Listing Rules, which were previously disclosed. While the appointment of Mr. Ren Chunyu as an Independent Non-Executive Director helps the company meet certain committee composition requirements, the company still falls short on critical rules, including the minimum number of independent non-executive directors and audit committee members, as well as board gender diversity. The company faces a three-month deadline to rectify these remaining deficiencies, highlighting ongoing governance challenges that could impact its listing status and investor confidence.
At the time of this filing, GRFXY was trading at $0.15 on OTC in the Manufacturing sector, with a market capitalization of approximately $7.6M. The 52-week trading range was $0.01 to $3.02. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.